TGN1412—a regulator's perspective
- 1 May 2006
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 24 (5) , 493-496
- https://doi.org/10.1038/nbt0506-493
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Regulation of Immune Responses by T CellsNew England Journal of Medicine, 2006
- Monoclonal antibody successes in the clinicNature Biotechnology, 2005
- Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitisThe Journal of Experimental Medicine, 2005
- Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomaProceedings of the National Academy of Sciences, 2003
- Topological Requirements and Signaling Properties of T Cell–activating, Anti-CD28 Antibody SuperagonistsThe Journal of Experimental Medicine, 2003
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996